Patients with early-stage liver cancer generally do not exhibit symptoms of fatigue, which are more commonly seen in patients with mid to late-stage liver cancer. The clinical symptoms of early-stage liver cancer are generally not typical, with a minority of patients experiencing reduced appetite and discomfort or mild pain in the liver area. Furthermore, early-stage liver cancer is often discovered during physical examinations or incidentally. Fatigue in liver cancer patients is mostly due to hypoalbuminemia, moderate to severe anemia, or toxic side effects caused by certain anticancer treatments. Hypoalbuminemia occurs because the growth of liver cancer consumes a large amount of protein, and liver dysfunction leads to insufficient synthesis of both protein and glycogen, resulting in malnutrition in patients. After experiencing weight loss, patients often show signs of fatigue. The pathological changes in liver cancer can lead to moderate to severe anemia, which, in turn, significantly contributes to fatigue. Additionally, some medications used in treating liver cancer can cause fatigue due to their toxic side effects.